Logo-ps

 

 

 

Follower of ICMJE

Powered by:
Mini Review

1. NSAIDs and COVID-19: A New Challenging Area
Hananeh Baradaran ORCID, Hadi Hamishehkar, Haleh Rezaee* ORCID
Pharm Sci. 2020;26(Suppl 1): S49-S51. doi: 10.34172/PS.2020.41
Scopus ID: 85097290006    
Article
PDF
XML
Cited By:
5
5
Review COVID-19

2. COVID-19: Clinical Characteristics and Molecular Levels of Candidate Compounds of Prospective Herbal and Modern Drugs in Indonesia
Robert Tungadi* ORCID, Teti Sutriyati Tuloli, Widysusanti Abdulkadir, Nurain Thomas, Madania Madania, Ani Mustapa Hasan, Zulfiayu Sapiun
Pharm Sci. 2020;26(Suppl 1): S12-S23. doi: 10.34172/PS.2020.50
Scopus ID: 85097264531    
Article
PDF
XML
Cited By:
5
3
Review COVID-19

3. COVID-19: A Devastating Pandemic
Punet Kumar* ORCID, Md Iftekhar Ahmad ORCID, Sangam Singh ORCID
Pharm Sci. 2020;26(Suppl 1): S3-S11. doi: 10.34172/PS.2020.34
Scopus ID: 85097274657    
Article
PDF
XML
Cited By:
3
4
Research Article COVID-19

4. In Silico Drug Repurposing of Penicillins to Target Main Protease Mpro of SARS-CoV-2
Baby Krishnaprasad ORCID, Swastika Maity ORCID, Chetan Mehta ORCID, Akhil Suresh ORCID, Usha Y Nayak ORCID, Yogendra Nayak* ORCID
Pharm Sci. 2020;26(Suppl 1): S52-S62. doi: 10.34172/PS.2020.44
Scopus ID: 85097296158    
Article
PDF
XML
Cited By:
3
3
Editorial COVID-19

5. Higher Education System in Light of Covid-19
Jalal Hanaee* ORCID, Mohammad Reza Rashidi ORCID
Pharm Sci. 2020;26(Suppl 1): S1-S2. doi: 10.34172/PS.2020.45
Scopus ID: 85097264895    
Article
PDF
XML
Cited By:
1
1
Review COVID-19

6. Investigational Drugs for the COVID 19 Pandemic – A Concise Review
Reena Sherin Parveen ORCID, Sherya Hegde, Veena Nayak* ORCID
Pharm Sci. 2020;26(Suppl 1): S36-S48. doi: 10.34172/PS.2020.80
Scopus ID: 85097283168    
Article
PDF
XML
Cited By:
1
0
Commentary COVID-19

7. Dexmedetomidine: An All Sedation-in–One Drug in Critically Ill Patients with COVID-19
Ata Mahmoodpoor, Elyad Ekrami, Hassan Soleimanpour* ORCID
Pharm Sci. 2020;26(Suppl 1): S80-S81. doi: 10.34172/PS.2020.53
Scopus ID: 85097267928    
Article
PDF
XML
Cited By:
5
2
Commentary COVID-19

8. Plasmapheresis: A New Strategy in the Treatment of COVID-19
Punet Kumar* ORCID, Md Iftekhar Ahmad ORCID, Sangam Singh ORCID
Pharm Sci. 2020;26(Suppl 1): S82-S83. doi: 10.34172/PS.2020.55
Scopus ID: 85097299809    
Article
PDF
XML
Cited By:
1
0
Commentary COVID-19

9. Persistence of SARS-Cov-2 on the Beauty Products, Their Containers’ Surfaces, and the Possibility of Secondary and Cross-Contamination
Zahra Jannatdoust, Sara Shamekhi, Jalal Hanaee, Somaieh Soltani* ORCID, Alireza Garjani*
Pharm Sci. 2020;26(Suppl 1): S84-S86. doi: 10.34172/PS.2020.68
Scopus ID: 85097293410    
Article
PDF
XML
Cited By:
2
2
Review COVID-19

10. A Summary of Coronavirus Disease 2019: What We Should Know?
Ysrafil Ysrafil ORCID, Indwiani Astuti* ORCID, Rosdiana Mus, Noviyanty Indjar Gama, Dwi Rahmaisyah, Riskah Nur’amalia
Pharm Sci. 2020;26(Suppl 1): S24-S35. doi: 10.34172/PS.2020.82
Scopus ID: 85097275654    
Article
PDF
XML
Cited By:
4
0
Commentary COVID-19

11. Diabetes and the COVID-19 Pandemic: What Should the Diabetes Patients Know?
Moyad Shahwan* ORCID, Nageeb Hassan, Sahab Alkhoujah, Ammar Jairoun ORCID, Samer Zyoud, Sudhir Varma
Pharm Sci. 2020;26(Suppl 1): S87-S90. doi: 10.34172/PS.2020.75
Scopus ID: 85097277524    
Article
PDF
XML
Cited By:
1
0
Research Article COVID-19

12. The Integration of Pharmacophore-Based 3D-QSAR Modeling and Virtual Screening in Identification of Natural Product Inhibitors against SARS-CoV-2
Samira Norouzi, Maryam Farahani, Samad Nejad Ebrahimi* ORCID
Pharm Sci. 2021;27(Suppl 1): S94-S108. doi: 10.34172/PS.2020.98
Scopus ID: 85117587296    
Article
PDF
Suppl 1
XML
Cited By:
5
2
Review COVID-19

13. The Clinical Characteristics and Treatment Approaches of COVID-19:A Concise Review
Sajjad Eslamkhah, Nazila Alizadeh, Khalil Hajiasgharzadeh, Masoud Eslamkhah, Ahad Mokhtarzadeh, Behzad Baradaran* ORCID
Pharm Sci. 2021;27(Suppl 1): S50-S67. doi: 10.34172/PS.2021.6
Scopus ID: 85118745536    
Article
PDF
XML
Cited By:
0
0
Research Article COVID-19

14. Qualitative and Quantitative Analysis of Anti-viral Compounds against SARS-CoV-2 Protease Enzyme by Molecular Dynamics Simulation and MM/PBSA Method
Saghi Sepehri* ORCID, Niloufar Hashemidanesh, Karim Mahnam, Hila Asham
Pharm Sci. 2021;27(Suppl 1): S122-S134. doi: 10.34172/PS.2021.4
Scopus ID: 85118789068    
Article
PDF
Suppl 1
XML
Cited By:
2
2
Review COVID-19

15. Anti-Rheumatic Drugs as Potential Anti-inflammatory, Immunomodulatory Agents against COVID-19: A Systematic Review
Reza Sinaei ORCID, Sara Pezeshki* ORCID, Ali Asadipour ORCID, Reza Shiari ORCID, Roya Sinaei ORCID, Ali Sinaei ORCID
Pharm Sci. 2021;27(Suppl 1): S13-S28. doi: 10.34172/PS.2021.40
Scopus ID: 85118713234    
Article
PDF
Suppl 1
XML
Cited By:
5
3
Commentary COVID-19

16. A Rapid Strategy for Repurposing Drugs for COVID-19
Maryam Khoubnasabjafari ORCID, Masoud Amanlou, Ahmadreza Dehpour, Abolghasem Jouyban* ORCID
Pharm Sci. 2020;26(Suppl 1): S91-S93. doi: 10.34172/PS.2020.76
Scopus ID: 85097265192    
Article
PDF
XML
Cited By:
1
0
Research Article COVID-19

17. Natural Products as Inhibitors of COVID-19 Main Protease – A Virtual Screening by Molecular Docking
Marzieh Omrani, Mohammad Bayati, Parvaneh Mehrbod* ORCID, Kamal Asmari Bardazard, Samad Nejad-Ebrahimi* ORCID
Pharm Sci. 2021;27(Suppl 1): S135-S148. doi: 10.34172/PS.2021.11
Scopus ID: 85117415904    
Article
PDF
Suppl 1
Suppl 2
XML
Cited By:
5
2
Research Article COVID-19

18. Molecular Docking and Dynamics Simulations Reveal the Potential of Anti-HCV Drugs to Inhibit COVID-19 Main Protease
Ahmed Ali Al-Karmalawy* ORCID, Radwan Alnajjar, Mohammed Dahab, Ahmed Metwaly, Ibrahim Eissa
Pharm Sci. 2021;27(Suppl 1): S109-S121. doi: 10.34172/PS.2021.3
Scopus ID: 85118951907    
Article
PDF
XML
Cited By:
45
19
Mini Review COVID-19

19. A New Possible Indication of Direct-acting Anti-hepatitis C Drugs in the Therapeutic Management of COVID-19: A Narrative Literature Review
Alireza Mashhadi Hemmatabadi ORCID, Fatemeh Jafari ORCID, Hesamoddin Hosseinjani* ORCID
Pharm Sci. 2021;27(Suppl 1): S78-S85. doi: 10.34172/PS.2021.23
Scopus ID: 85118716133    
Article
PDF
XML
Cited By:
0
1
Review COVID-19

20. The Impact of Vitamin D Supplementation on Mortality Rate and Clinical Outcomes of COVID-19 Patients: A Systematic Review and Meta-Analysis
Leila Nikniaz ORCID, Mohammad Amin Akbarzadeh ORCID, Hossein Hosseinifard ORCID, Mohammad-Salar Hosseini* ORCID
Pharm Sci. 2021;27(Suppl 1): S1-S12. doi: 10.34172/PS.2021.13
Scopus ID: 85115423983    
Article
PDF
Suppl 1
XML
Cited By:
26
13
Review COVID-19

21. Potential Roles of Vitamins in the Management of COVID-19: A Comprehensive Review
Homa Rezaei ORCID, Sajad Khiali ORCID, Hadis Rezaei, Haleh Rezaee, Hossein Bannazadeh Baghi, Matin Pourghasem, Taher Entezari-Maleki* ORCID
Pharm Sci. 2021;27(Suppl 1): S29-S49. doi: 10.34172/PS.2021.41
Scopus ID: 85118747204    
Article
PDF
XML
Cited By:
3
0
Review COVID-19

22. Acyclovir as a Potential Add-on Therapy in COVID-19 Treatment Regimens
Fatemeh Heidary* ORCID, Sedigheh Madani, Reza Gharebaghi* ORCID, Fahimeh Asadi-amoli
Pharm Sci. 2021;27(Suppl 1): S68-S77. doi: 10.34172/PS.2021.38
Scopus ID: 85118758701    
Article
PDF
XML
Cited By:
10
6
Review COVID-19

23. Clinical Efficacy of Hydroxychloroquine or Chloroquine in Patients with COVID-19: An Umbrella Review
Kavous Shahsavarinia ORCID, Morteza Ghojazadeh ORCID, Sarvin Sanaie, Leila Vahedi ORCID, Mahta Ahmadpour, Ata Mahmoodpoor, Hassan Soleimanpour* ORCID
Pharm Sci. 2021;27(4): 481-488. doi: 10.34172/PS.2021.66
Scopus ID: 85127179298    
Article
PDF
XML
Cited By:
3
1

   Indexing & Abstracting: